MedTrace Logo

PORTHOS - PORTuguese Heart Failure Observational Study

NCT05434923 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6189

Last updated 2024-08-26

No results posted yet for this study

Summary

This study aims to determine the prevalence of heart failure in the resident population in mainland Portugal aged 50 years or above, using a contemporary, guideline-based diagnostic approach, to optimize patient management and improve strategic healthcare decision-making

Conditions

Sponsors & Collaborators

  • Sociedade Portuguesa de Cardiologia

    collaborator UNKNOWN

  • NOVA Medical School

    collaborator OTHER

  • AstraZeneca

    lead INDUSTRY

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2023-09-18
Completion
2023-09-18

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05434923 on ClinicalTrials.gov